Colorado Prescription Drug Affordability Board Selecting High-Cost Drugs For Review & Possible Price Caps

During the summer of 2023, Colorado’s Prescription Drug Affordability Board will choose up to 18 high-cost drugs to be included in its first affordability review cycle. The board has not released the list of medications under consideration for review. The goal is to determine if the medications’ list prices are unaffordable for Colorado consumers. For those deemed unaffordable, the board is authorized to establish upper payment limits. The upper payment limit would apply to all purchases of and payer reimbursements for the prescription drug dispensed or administered to individuals in the state in person, by mail, or by . . .